Should You Buy Huntsman Corp (HUN) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/29
Huntsman (HUN) is not a good buy right now for a beginner, long-term investor who’s impatient about entry timing. The stock has some constructive longer-term technical structure (short MAs above longer MAs) and meaningful insider buying, but near-term price momentum is weakening (bearish MACD), the latest quarter shows deteriorating profitability, options flow is leaning defensive in daily volume, and the next-month pattern outlook is negative. Net: HOLD/AVOID new buying at current levels around $11.50.
Technical Analysis
Trend/momentum: The moving averages are bullish (SMA_5 > SMA_20 > SMA_200), which supports a longer-term base/recovery setup. However, MACD histogram is negative (-0.0624) and expanding to the downside, signaling weakening momentum in the near term. RSI(6) at ~44 is neutral-to-soft, consistent with a market that can still drift lower.
Levels: Price ($11.50) is below the pivot (11.767), suggesting overhead resistance nearby. Key support is S1 at 11.284 (a break increases risk toward S2 at 10.985). Resistance levels are 12.25 (R1) then 12.549 (R2).
Quant pattern outlook provided: Similar-pattern stats imply ~+5.75% potential over the next week, but a -10.2% bias over the next month—this mismatch reinforces that the trade may be choppy with downside risk if the broader chemicals demand backdrop stays weak.
Intellectia Proprietary Trading Signals
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock today.
Analyst Ratings and Price Target Trends
Recent trend: Price targets were broadly raised in Dec–Jan (RBC to $13, Citi to $10.50, Goldman to $9.50, Mizuho to $8), but ratings remain mixed-to-cautious. Notably, several firms are still negative (Goldman Sell, Mizuho Underperform) and one remains constructive (JPMorgan Overweight, though it cut PT sharply to $11 from $20).
Wall Street pros: (1) Portfolio transformation and reduced exposure to lower-multiple cyclicals, (2) potential ‘trough’ earnings multiple argument, (3) upside if demand recovers.
Wall Street cons: (1) Unprecedented weak demand and pricing pressure, (2) near-term earnings pressure and delayed recovery, (3) mixed conviction—targets up, but ratings still lean cautious.
Influential/politician trading: No recent congress trading data available in the past 90 days (no signal from that channel).
Wall Street analysts forecast HUN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HUN is 9.78 USD with a low forecast of 8 USD and a high forecast of 11 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast HUN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HUN is 9.78 USD with a low forecast of 8 USD and a high forecast of 11 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 11.410
Current: 11.410
